2. • Gross revenues of R$845.4 million, an increase of 13.2% over 2Q12.
• Gross Margin of 31.5%, 1.4 p.p. over 2Q12
• Total SSS (same-store sales) of 9.8%, with 5.3% for mature stores
• Adjusted EBITDA of R$48.4 million, with adjusted EBITDA margin of 5.7%
• Adjusted net income of R$7.9 million, with adjusted net margin of 0.9%
• With the opening of 25 new owned stores and 27 franchisees, we ended 2Q13 with 1,160 stores.
• Inauguration of a new distribution center in Recife
Operational & Financial
4. 25 openings (34 in 1H13)
7 closings (15 in 1H13)
39.5% of owned stores not yet at mature
stage
12.4%
14.4%
12.7%60.5%
Stores with less than 12 months
Stores with 12 to 24 months
Stores with 24 to 36 months
Stores with more than 36 months
25
7
12. Cash position and indebtedness (R$'000) 2Q12 4Q12 1Q13 2Q13
(+) Loans and financing 159,908 177,049 169,079 160,228
Short term 48,123 83,229 44,864 41,694
Long term 111,785 93,820 124,215 118,534
(+) Debentures 254,879 253,642 258,937 253,964
Short term 6,688 5,237 10,427 5,348
Long term 248,191 248,405 248,510 248,616
(+) Accounts payable for investment acquisition 498,242 345,333 264,430 232,581
Short term 244,986 99,711 82,833 81,986
Long term 253,256 245,622 181,597 150,595
(=) Total Indebtedness 913,029 776,024 692,446 646,773
Short term (%) 32.8% 24.2% 19.9% 19.9%
Long term (%) 67.2% 75.8% 80.1% 80.1%
(-) Cash and cash equivalents (411,267) (368,751) (183,870) (162,205)
(=) Net Debt 501,762 407,273 508,576 484,568
Net debt/Adjusted EBITDA (LTM) 2.9 X 2.1 X 2.7 X 2.5 X
13. 746
6
27
12
23
Working capial 2Q12 4Q12 1Q13 2Q13
Accounts receivable 25 23 24 18
Inventories 92 95 106 109
Suppliers 54 58 55 73
Working capital in days 63 60 75 53
14. Cash flow Statement (R$'000) 2Q12 2Q13 1H12 1H13
EBT 7,795 11,158 18,021 3,605
(+) Depreciation and amortization 12,268 17,054 28,360 33,516
(+) Others 12,896 (4,175) 26,038 20,214- -
Operating cash generation 32,959 24,037 72,419 57,335
(+) Change in working capital (93,559) 159,077 (151,092) 75,935
(+) Change in other assets and liabilities (41,623) (104,886) (55,541) (118,669)
Cash consumption (135,182) 54,191 (206,633) (42,734)
Net cash generated by operating activities (102,223) 78,228 (134,214) 14,601
(-) Capex from operations (28,176) (49,033) (47,723) (73,953)
(-) Acquisitions (41,566) (31,848) (327,898) (112,751)
Net Cash from investing activities (69,742) (80,881) (375,621) (186,704)
(+/-) Loans and financing 62,480 (25,986) 258,755 (41,417)
(+) Equity funding / Dividends 397,851 6,975 398,792 6,975
Net Cash from financing activities 460,331 (19,011) 657,547 (34,442)
Change in cash and cash equivalents 288,366 (21,664) 147,712 (206,545)
Cash and cash equivalents - opening balance 122,901 183,870 263,555 368,751
Cash and cash equivalents - closing balance 411,267 162,205 411,267 162,205
15. Back-Office Adm. (SSC) SAP - Back-Office
Operation integrated (SSC).
Continuous improvement phase
Pre-"Go Live" tests cycle
Will be integrated in 2014
Mapping phase and "Go live" in
2014
Operation integrated (SSC).
Continuous improvement phase
Pre-"Go Live" tests cycle
Operation integrated (SSC).
Continuous improvement phase
Pre-"Go Live" tests cycle
Status 75% 50%
Administrative (SSC)
16. Logistics Trade Marketing Procurement
New DC
(Nov 2012)
Stores remodeling (2012):
28% increase in HPC
Procurement integrated
New DC
(Jun 2013)
Actions to improve generics
sales in practice
Procurement Integration
expected to 2014
New DC
FC (Out 2013)
Focus in remodeling to
standardize mix and layout
Procurement integrated
New DC
(Out 2012)
Mix and store layout
standardized
Procurement integrated
Status 70% 60% 60%
Commercial
17. Sales Training Culture Meritocracy POS system Growth strategy
"Vendo Mais" Program
in practice
New Brasil Pharma logo
(endorsement)
Standardization of
variable compensation
implemented
Unique system under
analysis
Store openings:
countryside of Bahia
"Vendo Mais" Program
in practice
New Brasil Pharma logo
(endorsement)
Standardization of
variable compensation
to be implemented
Unique system under
analysis
Store openings in N/NE
"Vendo Mais" Program
in practice
New Brasil Pharma logo
(endorsement)
Standardization of
variable compensation
implemented
Unique system under
analysis
Store closings: sales
bellow BRPH average
"Vendo Mais" Program
in practice
New Brasil Pharma logo
(endorsement)
Standardization of
variable compensation
implemented
Unique system under
analysis
Store openings:
countryside of MT and
GO
Status 100% 100% 80% 0% 80%
Operations
